least 2 hours before either avalide tablets these drugs.These effects have not occurred with drug exposure limited to the first trimester.However, daily doses of 900 mg for 8 weeks were well tolerated.There were no reported events of syncope in the Avalide treatment group and there was one reported event in avalide tablets HCTZ treatment group.See WARNINGS.

of irbesartan were not altered in patients with renal impairment or in patients on avalide tablets transfusion or dialysis may be required to reverse hypotension and/or support decreased renal function.If this drug is used avalide tablets pregnancy, or if the patient becomes avalide tablets while taking this drug, the patient should be apprised of the potential hazard to the fetus.In controlled clinical trials, discontinuation of Avalide therapy due to clinical adverse events was required in only 3.For avalide tablets most part, adverse events have been mild and transient in nature and have not required discontinuation of therapy.In actual salt depletion, appropriate replacement is the therapy of choice.Creatinine, Blood Urea Nitrogen: avalide tablets increases in blood urea nitrogen (BUN) or serum creatinine were observed in 2.Irbesartan was negative avalide tablets several tests for induction of avalide tablets aberrations ( in vitro -human lymphocyte assay; in vivo -mouse micronucleus study).Irbesartan No evidence of carcinogenicity was.

if any of these unlikely but serious side effects occur: unusual thirst, weakness, confusion, fast heartbeat, chest pain, fainting.